[ad_1]
LOS ANGELES – (BUSINESS WIRE) – Oct. 26, 2018 – CHA CHA HPMC (CHA Hollywood Presbyterian Medical Center), a subsidiary of CHA Health Systems, a global leader in biotechnology and healthcare, and Dr. Rohit Varma have established a partnership to form the new Southern California Vision and Vision Research Institute (SCEVRI) to provide specialized, comprehensive eye care and advanced therapies to the diverse communities of Southern California, and to conduct World-clbad research in collaboration with CHA's leading-edge stem cell research platform.
This press release presents multimedia. See the full press release here: https://www.businesswire.com/news/home/20181026005485/en/
Bob Allen, CHA President and CEO of CHA's Hollywood Presbyterian Medical Center Welcomes Rohit Varma, MD, MPH, to Lead New California Eye Care and Vision Research Institute of the South as founding director (Photo: Business Wire)
According to the latest research, southern California has a high incidence of underdiagnosed and under-treated eye diseases. The number of people with visual impairment (VI) and blindness is increasing in California and the United States due to demographic change, aging of the population and the high incidence of diabetes. A study published in the Journal of the American Medical Association (JAMA) predicts that African-American people have the highest prevalence of visual impairment and blindness. By 2050, the highest prevalence of HIV among minorities will pbad people of African-American descent (15.2% in 2015 to 16.3% in 2050) to those originally born Hispanic (9.9% in 2015 to 20.3% in 2050). Multiracial Americans and Hispanic whites from California will remain the largest demographic group with visual impairment between 2015 and 2060.
The new Eye Care Research Institute will lead vision research in diverse communities and vulnerable populations – using Big Data and Artificial Intelligence to develop new therapies, stem cell therapies and regeneration, in the United States and abroad – to improve the eye health of patients.
"Our ophthalmic institute will make rapid scientific and technological advances, from stem cells to new anti-glaucoma devices, to the artificial retina," said Dr. Rohit Varma. "As a team, we will take bold steps to better understand, prevent and create innovative treatments to manage diseases that lead to vision loss and blindness, making visible hope for our patients." patients through innovative research and evidence-based eye care Innovative research and vision care focused on developing new ways to change the lives of our patients by ending vision loss and to blindness.
An accomplished medical scientist, Varma is recognized around the world as a visionary leader in the field of glaucoma and the epidemiology of eye diseases. He is an expert on optic nerve changes in glaucoma and is also studying new imaging techniques in the early diagnosis of glaucomatous optic nerve lesions. Her main research focuses on epidemiological studies of eye diseases in children and aging populations.
"We are excited to welcome Dr. Varma into the team," said Robert Allen, president and CEO of CHA HPMC. "Our company, CHA Health Systems, has pioneered stem cell research and is known for its stem cell research. CHA – SCEVRI will deliver on its commitment to providing the highest quality eye care to communities."
About CHA Hollywood Presbyterian Medical Center
The CHA Hollywood Presbyterian Medical Center (CHA HPMC) is a nationally renowned acute care facility that has been taking care of Hollywood and its surrounding communities since 1924. Today, CHA HPMC offers comprehensive health services with an acute care facility of 434 beds, including 89 registered nurses. beds. The hospital employs more than 500 doctors and specialists, representing 69 specialties and 75 countries. CHA HPMC adheres to the diverse multicultural populations of patients in the region by providing quality compbadionate care to all who walk through its doors. He is a member of CHA Health Systems, a dynamic global health organization with acute care hospitals, fertility clinics and medical research centers in Korea, Armenia, Japan, Taiwan, Singapore, Singapore, Australia, Hawaii and CHA fertility centers in Los Angeles. Angeles and Buena Park, California.
Health Analytics has awarded CHA HPMC the following quality awards: Patient Safety, Labor & Delivery, Obstetrics & Gynecology, Back Surgery, Hip Fracture Treatment and Heart Failure Treatment. For more information, visit www.hollywoodpresbyterian.com/.
About CHS Health Systems
CHA Health Systems (www.en.chamc.co.kr), headquartered in Pan-gyo, Korea, is a global leader in the biotechnology sector, consisting of 25 hospitals and clinics, 27 research institutions and 7 educational institutions and 28 bio / pharmaceutical / health companies. CHA Health Systems, provides world-clbad care in all areas of medicine, including research and clinical work in the field of fertility and advanced therapies using cord blood stem cells and cells Immunity.
About Dr. Rohit Varma
Prior to founding SCEVRI, Varma was professor of ophthalmology and preventive medicine and holder of the Grace and Emery Beardsley Chair in Ophthalmology at the USC's Keck School of Medicine. Previously, he was dean of the USC's Keck School of Medicine and chairman and chairman of the board of USC Care. He was also Chair of the USC Department of Ophthalmology and Founding Director of the USC Gayle and the Edward Roski Eye Institute and was Associate Dean of Strategic Planning and Community Network Development.
An accomplished world-renowned medical scientist, Varma is recognized as a visionary leader in the field of glaucoma and the epidemiology of eye diseases. He is an expert on optic nerve changes in glaucoma and is also studying new imaging techniques in the early diagnosis of glaucomatous optic nerve lesions. Her main research focuses on epidemiological studies of eye diseases in children and aging populations. He is the principal investigator of several studies funded by the National Institute of Health, including the Los Angeles Latino Eye Study, the Chinese American Eye Study, the Multi-Ethnic Pediatric Eye Diseases Study and the African American Eye Disease Study. His epidemiological studies have had a significant impact on health policy and helped to better understand how the disease affects different populations. He has also been a principal investigator for studies on blindness and visual impairment for the World Health Organization. More recently, Varma has been involved in the use of large databases and artificial intelligence in the detection and monitoring of diseases, as well as in the development of new intraocular pressure sensors and devices. implantable drainage.
Previously, Mr. Varma was also Professor and Chair of the Illinois Eye and Ear Infirmary at the University of Illinois at Chicago, where he chaired the Charles I. Young Chair in Eye Research and was Associate Dean of Strategic Planning. .
Originally from India, Dr. Varma earned his medical degree at the University of Delhi. He then completed his residency in Ophthalmology at Johns Hopkins Hospital in Baltimore and earned a Master of Public Health degree from Johns Hopkins University. Dr. Varma has conducted two glaucoma research fellowships, one at the Wills Eye Hospital in Philadelphia and the other at the USC.
See the source version on businesswire.com:https://www.businesswire.com/news/home/20181026005485/en/
CONTACT: ACS Presbyterian Medical Center in Hollywood
Su Lee
Public relations
+ 1-323-906-6064
KEYWORD: NORTH AMERICA, UNITED STATES, CALIFORNIA
KEYWORDS INDUSTRY: STEM CELLS HEALTH BIOTECHNOLOGY OPTICAL RESEARCH HOSPITALS SCIENCE
SOURCE: CHA Hollywood Presbyterian Medical Center
Copyright Business Wire 2018.
PUB: 26/10/2018 13:54 PM / DISC: 10/26/2018 13:54 PM
http://www.businesswire.com/news/home/20181026005485/fr
Source link
